Sichuan Kelun Pharmaceutical Co.,Ltd.
1 clinical trials · Sponsor
◉ Watch Sichuan Kelun Pharmaceutical Co.,Ltd.
| Record | Firm | Date |
|---|---|---|
| The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. (NCT06674694) | Sichuan Kelun Pharmaceutical Co.,Ltd. | 2024-04-10 |
Track Sichuan Kelun Pharmaceutical Co.,Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.